DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.

Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the firm was ...

IonQ Inc.‘s (NYSE:IONQ) shares are barreling higher Thursday after the company reported better-than-expected third-quarter ...

SINGAPORE – Pharmaceutical giant AstraZeneca is set to create over 800 skilled jobs here to staff a new manufacturing facility in Tuas South. The jobs range from those in engineering and technical ...

Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer settingFinancial visibility confirmed into Q4 2025 Strasbourg, France ...

With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...

AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy the stock as the big ...

Aptamer's Optimer technology achieves key milestones in genetic medicine delivery, enhancing targeting specificity and ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

Gatestone Institute senior fellow Gordon Chang discusses Trump's potential foreign policy regarding China and the hacking ...